E227 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan ...

What are the properties of lithium that make it a unique treatment option? What are the main reasons why lithium is underutilized in clinical practice, and what are the consequences of underutilization? What are the common myths or misconceptions about lithium’s safety and tolerability? How can we better educate patients about the benefits of lithium and address concerns about side effects or monitoring requirements that may impact adherence?
Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on underutilized psychotropic drugs.
Today, Dr. Andy Cutler interviews Dr. Jonathan Meyer and Dr. Stephen Stahl about factors that have led to the underutilization of lithium in psychiatry.
Let’s listen to Part 1 of our theme: Underutilized Psychiatric Drugs.
Subscribe to the NEI Podcast, so that you don’t miss another episode!

Resource
The Lithium Handbook (www.cambridge....)

[@kenhaze5230]

"Patients are going to do what they want." Probably a good rational expectation. But they can also follow instructions. You talk about using novel atypicals to try and avoid clozapine because of the prescriber burden, but what about MAOIs? I get the sense even a lot of psychs expect patients to say "thank you doc. Now, irrespective of what you say, I'm going to go take my selegiline, and then eat from between five on up to twelve wheels of gouda immediately." Especially for atypical depression where the third SSRI probably isn't going to do anything more than the first two trialed.

[@mansoorahmad8409]

great ❤

[@bsarora1]

good one